Show simple item record

Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer

dc.contributor.authorCoulson-Gilmer, C
dc.contributor.authorHumphries, M P
dc.contributor.authorSundara Rajan, S
dc.contributor.authorDroop, A
dc.contributor.authorJackson, S
dc.contributor.authorCondon, A
dc.contributor.authorCserni, G
dc.contributor.authorJordan, L B
dc.contributor.authorJones, J L
dc.contributor.authorKanthan, R
dc.contributor.authorDi Benedetto, A
dc.contributor.authorMottolese, M
dc.contributor.authorProvenzano, E
dc.contributor.authorKulka, J
dc.contributor.authorShaaban, A M
dc.contributor.authorHanby, A M
dc.contributor.authorSpeirs, V
dc.date.accessioned2018-08-31T09:18:06Z
dc.date.available2018-08-31T09:18:06Z
dc.date.issued2018-10
dc.identifier.citationCoulson-Gilmer , C , Humphries , M P , Sundara Rajan , S , Droop , A , Jackson , S , Condon , A , Cserni , G , Jordan , L B , Jones , J L , Kanthan , R , Di Benedetto , A , Mottolese , M , Provenzano , E , Kulka , J , Shaaban , A M , Hanby , A M & Speirs , V 2018 , ' Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer ' , The Journal of Pathology. Clinical Research , vol. 4 , no. 4 , pp. 241-249 . https://doi.org/10.1002/cjp2.106en
dc.identifier.issn2056-4538
dc.identifier.otherPURE: 129545803
dc.identifier.otherPURE UUID: e5244fd1-89cc-41c2-9482-5b366211a4e6
dc.identifier.otherPubMed: 29956502
dc.identifier.otherORCID: /0000-0002-0602-4666/work/72631271
dc.identifier.otherScopus: 85054428947
dc.identifier.urihttp://hdl.handle.net/2164/11025
dc.descriptionFunding Information Breast Cancer Now. Grant Number: TBLEE2017 Yorkshire Cancer Research. Grant Number: L378en
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofThe Journal of Pathology. Clinical Researchen
dc.rights© 2018 The Authors. The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. https://creativecommons.org/licenses/by-nc/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectJournal Articleen
dc.subjectmale breast canceren
dc.subjectstanniocalcin 2en
dc.subjectimmunochemistryen
dc.subjectsurvivalen
dc.subjectRB Pathologyen
dc.subject.lccRBen
dc.titleStanniocalcin 2 expression is associated with a favourable outcome in male breast canceren
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1002/cjp2.106
dc.identifier.vol4en
dc.identifier.iss4en


Files in this item

Thumbnail
Name:
Coulson_Gilmer_et_al_2018_The_ ...
Size:
726.3Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record